These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32010948)

  • 1. Can the Public Be Educated About Constituents in Smokeless Tobacco? A Three-Wave Randomized Controlled Trial.
    Loken B; Borgida E; Wang T; Madzelan MK; Williams AL; Hatsukami D; Stepanov I
    Nicotine Tob Res; 2021 Jan; 23(1):161-170. PubMed ID: 32010948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Transitions Between Cigarette and Smokeless Tobacco Product Use in the United States Using the 2002-2003 and 2010-2011 Longitudinal Cohorts.
    Chang JT; Levy DT; Meza R
    Nicotine Tob Res; 2018 Sep; 20(11):1412-1416. PubMed ID: 29126271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
    Wackowski OA; O'Connor RJ; Pearson JL
    Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Constituent Levels in Smokeless Tobacco Products: A New Approach to Engaging and Educating the Public.
    Borgida E; Loken B; Williams AL; Vitriol J; Stepanov I; Hatsukami D
    Nicotine Tob Res; 2015 Nov; 17(11):1354-61. PubMed ID: 25634934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014).
    Cheng YC; Reyes-Guzman CM; Christensen CH; Rostron BL; Edwards KC; Wang L; Feng J; Jarrett JM; Ward CD; Xia B; Kimmel HL; Conway K; Leggett C; Taylor K; Lawrence C; Niaura R; Travers MJ; Hyland A; Hecht SS; Hatsukami DK; Goniewicz ML; Borek N; Blount BC; van Bemmel DM
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):659-667. PubMed ID: 31988072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicating Tobacco Product Information to the Public.
    Berman ML; Byron MJ; Hemmerich N; Lindblom EN; Lazard AJ; Peters E; Brewer NT
    Food Drug Law J; 2017; 72(3):386-405. PubMed ID: 29398886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smokeless tobacco mortality risks: an analysis of two contemporary nationally representative longitudinal mortality studies.
    Fisher MT; Tan-Torres SM; Gaworski CL; Black RA; Sarkar MA
    Harm Reduct J; 2019 Apr; 16(1):27. PubMed ID: 30975137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Online Information About Harmful Tobacco Constituents: A Content Analysis.
    Margolis KA; Bernat JK; Keely O'Brien E; Delahanty JC
    Nicotine Tob Res; 2017 Oct; 19(10):1209-1215. PubMed ID: 27613931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Motives for Use Among Polytobacco Versus Cigarette Only Users and Among Single Tobacco Product Users.
    Wong EC; Haardörfer R; Windle M; Berg CJ
    Nicotine Tob Res; 2017 Dec; 20(1):117-123. PubMed ID: 27798088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes.
    Czoli CD; Fong GT; Mays D; Hammond D
    Tob Control; 2017 Mar; 26(e1):e49-e58. PubMed ID: 27625408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported exposure to tobacco warning labels among U.S. middle and high school students.
    Johnson SE; Wu CC; Coleman BN; Choiniere CJ
    Am J Prev Med; 2014 Aug; 47(2 Suppl 1):S69-75. PubMed ID: 25044198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
    Wang Y; Wong LY; Meng L; Pittman EN; Trinidad DA; Hubbard KL; Etheredge A; Del Valle-Pinero AY; Zamoiski R; van Bemmel DM; Borek N; Patel V; Kimmel HL; Conway KP; Lawrence C; Edwards KC; Hyland A; Goniewicz ML; Hatsukami D; Hecht SS; Calafat AM
    Environ Int; 2019 Feb; 123():201-208. PubMed ID: 30530162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interviews with smokers about smokeless tobacco products, risk messages and news articles.
    Wackowski OA; Lewis MJ; Delnevo CD
    Tob Control; 2016 Nov; 25(6):671-678. PubMed ID: 26576840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal pathways of exclusive and polytobacco smokeless use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).
    Sharma E; Edwards KC; Halenar MJ; Taylor KA; Kasza KA; Day H; Gardner LD; Anic G; Bansal-Travers M; Limpert J; Hammad HT; Borek N; Kimmel HL; Compton WM; Hyland A; Stanton CA
    Tob Control; 2020 May; 29(Suppl 3):s170-s177. PubMed ID: 32321851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Use of Smokeless Tobacco in US Adults, 2013-2014.
    Cheng YC; Rostron BL; Day HR; Stanton CA; Hull LC; Persoskie A; Travers MJ; Taylor K; Conway KP; Ambrose BK; Borek N
    Am J Public Health; 2017 Sep; 107(9):1508-1514. PubMed ID: 28727534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and predictors of smokeless tobacco use among adults in Bangladesh: findings from the International Tobacco Control (ITC) Bangladesh survey.
    Abdullah AS; Driezen P; Ruthbah UH; Nargis N; Quah AC; Fong GT
    PLoS One; 2014; 9(7):e101934. PubMed ID: 25007266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Harmful Constituent Profiles in Smokeless Tobacco Products from Five African Countries.
    Gomez F; Ayo-Yusuf O; Yershova K; Jain V; Alcheva A; Hatsukami DK; Parascandola M; Stepanov I
    Chem Res Toxicol; 2023 Dec; 36(12):1901-1911. PubMed ID: 38051542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do Bangladeshi people use smokeless tobacco products?
    Rahman MA; Mahmood MA; Spurrier N; Rahman M; Choudhury SR; Leeder S
    Asia Pac J Public Health; 2015 Mar; 27(2):NP2197-209. PubMed ID: 22652250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Youth and adult understanding of public displays of information about harmful constituents in cigarette smoke.
    Venrick SJ; Margolis KA; Bernat JK; Pepper JK; Nonnemaker JM; Eggers ME
    Prev Med; 2023 Apr; 169():107458. PubMed ID: 36813248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smokeless Tobacco in Uganda: Perceptions among Tobacco Control Stakeholders.
    Male D; Kansabe S; Lukwata H; Rubanga A; Siddiqi K; Bauld L; McNeill A; Dobbie F
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.